Results 131 to 140 of about 24,189 (241)

Supplementary Figures from Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis

, 2019
Supplementary Figure S1: Overall study design for multi-omic data analysis. Supplementary Figure S2: The distribution of beta-values in DNA methylation data.
So Mee Kwon (14944617), Gi Hong Choi (14944620), Jeong Eun Yoo (8769095), Youngsic Jeon (1838872), Hyungjin Rhee (616104), Hyun Goo Woo (9206824), Ji Hae Nahm (3821056), Byul A Jee (14944614), Young Nyun Park (149284), Ji-Hye Choi (106902), Sarah Yoon (2671738)   +10 more
core   +1 more source

Advantages of the proposed fibrosis-associated hepatocarcinogenesis models in males and females.

, 2018
Advantages of the proposed fibrosis-associated hepatocarcinogenesis models in males and females.
Guilherme Ribeiro Romualdo (5746643), Ana Angélica Henrique Fernandes (4020731), Bruno Cogliati (5102438), Gabriel Bacil Prata (5746646), Fernando Salvador Moreno (5746652), Luís Fernando Barbisan (5746655), Tereza Cristina da Silva (5746649)   +6 more
core   +1 more source

Genetic Control of Resistance to Hepatocarcinogenesis by the Mouse Hpcr3 Locus

, 2008
Hepatology. 2008 Aug;48(2):617-23. Genetic control of resistance to hepatocarcinogenesis by the mouse Hpcr3 locus. Manenti G, Galvan A, Falvella FS, Pascale RM, Spada E, Milani S, Gonzalez Neira A, Feo F, Dragani TA. Source Department of Experimental
NEIRA A. G, GALVAN A, FALVELLA S, MILANI S, MANENTI G, SPADA E, PASCALE, Rosa Maria, FEO F, DRAGANI T. A.   +8 more
core  

New insights on the role of epigenetic alterations in hepatocellular carcinoma

Journal of Hepatocellular Carcinoma, 2014
Maddalena Frau,1 Claudio F Feo,2 Francesco Feo,1 Rosa M Pascale11Department of Clinical and Experimental Medicine, Division of Experimental Pathology and Oncology, 2Department of Clinical and Experimental Medicine, Division of Surgery.
Frau M, Feo CF, Feo F, Pascale RM
doaj  

Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis

Reviewed By Yoesoep Edhie Rachmad, Web of Science (Clarivate SSO) Researcher ID GRE-6442-2022, Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis Acta Pharmaceutica Sinica B 2025 | Journal article DOI: 10.1016/J.APSB.2025.01.017 WOSUID:
Prof. Dr. Yoesoep Edhie Rachmad, Ph.D, DBA
core  

Hepatocarcinogenesis [PDF]

, 2020
openaire   +1 more source

The Role of Hepatitis B Viral Protein HBx in Hepatocarcinogenesis

With approximately 296 million individuals estimated worldwide, the chronic infection of hepatitis B virus (HBV) is one of the most common risk factors for hepatocellular carcinoma (HCC).
Muroyama, Ryosuke
core  

Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 6710. [PDF]

Int J Mol Sci
Nishimura N, Kaji K, Nishimura N, Hanatani J, Nakatani T, Oyama M, Shibamoto A, Tsuji Y, Kitagawa K, Sato S, Namisaki T, Tamaoki S, Yoshiji H.   +12 more
europepmc   +1 more source

Erratum: Overexpression of Platelet-Derived Growth Factor Receptor Α <i>D842V</i> Mutants Prevents Liver Regeneration and Chemically Induced Hepatocarcinogenesis via Inhibition of MET and EGFR: Erratum. [PDF]

J Cancer
Du ZQ, Dong J, Li MX, Zhang JF, Bi JB, Ren YF, Zhang LN, Wu RQ, Monga SPS, Lv Y, Zhang XF, Wang HC.   +11 more
europepmc   +1 more source

FOXO6 as a Transcriptional Regulator of Hepatic Metabolic Inflammation and Hepatocarcinogenesis. [PDF]

IUBMB Life
Kim ME, Kim Y, Lee JS.
europepmc   +1 more source